Cargando…

Reply to Jin et al. and to Sun et al.

Detalles Bibliográficos
Autores principales:	Boucly, Athénaïs, Weatherald, Jason, Savale, Laurent, Jaïs, Xavier, Montani, David, Humbert, Marc, Sitbon, Olivier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Thoracic Society 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8865711/ https://www.ncbi.nlm.nih.gov/pubmed/34672868 http://dx.doi.org/10.1164/rccm.202107-1725LE

Ejemplares similares

Pulmonary Vascular Resistance in Pulmonary Arterial Hypertension: La Pièce de Résistance?
por: Weatherald, Jason, et al.
Publicado: (2021)

Sequential combination therapy with parenteral prostacyclin in BMPR2 mutations carriers
por: Boucly, Athénaïs, et al.
Publicado: (2022)

Reply to Jha
por: Montani, David, et al.
Publicado: (2022)

Acute decompensated pulmonary hypertension
por: Savale, Laurent, et al.
Publicado: (2017)

Reply by Pan et al. to Haouzi et al.
por: Pan, Chun, et al.
Publicado: (2020)

Reply to Fillatre et al. and Li et al.
por: Abdul-Aziz, Mohd H., et al.
Publicado: (2022)

Reply to Jin et al.: Inhaled Treprostinil after Initial Clinical Worsening: To Continue or Not to Continue, That’s the Question
por: Nathan, Steven D.
Publicado: (2022)

Reply to Nie et al. and Bhammar et al.
por: Peters, Michael C., et al.
Publicado: (2022)

Reply to Boyd et al
por: Solomon, Marc M., et al.
Publicado: (2015)

Reply to Pawaskar et al.
por: Akpo, E I Hervé, et al.
Publicado: (2021)

Reply to Butler et al.
por: Eskandari, Mona, et al.
Publicado: (2023)

Reply to Lescoat et al. and to Khamis et al.
por: Adegunsoye, Ayodeji, et al.
Publicado: (2019)

Reply to Chase et al. and to Milner et al.
por: Mittel, Aaron M., et al.
Publicado: (2020)

Reply by Xu et al. to Haouzi et al.
por: Xu, Yonghao, et al.
Publicado: (2020)

Reply to Topeli et al. and to Akinosoglou et al.
por: Azevedo, Luciano C. P., et al.
Publicado: (2020)

Reply to Turnbull et al. and to Hulme et al.
por: Breuer, Oded, et al.
Publicado: (2020)

Reply to Shoemark et al. and to Shapiro et al.
por: Amirav, Israel, et al.
Publicado: (2020)

Reply to Gueret et al. and to Hammond et al.
por: Brown, Ryan M., et al.
Publicado: (2020)

Reply to Blot et al. and to Inoue et al.
por: McElvaney, Oliver J., et al.
Publicado: (2021)

Reply to Sanfilippo et al. and to Caviedes et al.
por: Arachchillage, Deepa J., et al.
Publicado: (2021)

Screening for pulmonary arterial hypertension in systemic sclerosis
por: Weatherald, Jason, et al.
Publicado: (2019)

Reply to T. Hasegawa et al and I. Gross et al
por: Leyland-Jones, Brian, et al.
Publicado: (2016)

Reply to Cottin et al., to Johannson et al., to Scholand and Wells, and to Crowley et al.
por: Raghu, Ganesh, et al.
Publicado: (2022)

Reply to Q. Chu et al
por: Semprini, Jason T., et al.
Publicado: (2021)

THARYAN ET AL REPLY
por: Tharyan, Prathap, et al.
Publicado: (1994)

THARYAN ET AL'S REPLY
por: Tharyan, Prathap
Publicado: (1995)

Reply to Pawar et al
por: Todd, Stacy, et al.
Publicado: (2014)

Reply to Farmakiotis et al
por: Waddington, Claire S., et al.
Publicado: (2014)

Reply to Cunnington et al
por: Hanson, Josh, et al.
Publicado: (2013)

Reply to Yates et al
por: Middelkoop, Keren, et al.
Publicado: (2015)

Reply to Goyal et al
por: Hsiang, Michelle S., et al.
Publicado: (2015)

Reply to Worth et al
por: Mitchell, Brett G., et al.
Publicado: (2014)

Reply to Sauvage et al
por: Desnues, Christelle, et al.
Publicado: (2014)

Reply to Thysen et al
por: Tchakoute, Christophe Toukam, et al.
Publicado: (2015)

Reply to Rossi et al
por: Hsiang, Michelle S, et al.
Publicado: (2017)

Reply to Dian et al
por: Thao, Le Thi Phuong, et al.
Publicado: (2018)

Reply to Kempf et al
por: Thorne, L., et al.
Publicado: (2017)

Reply to S. Rastogi et al
por: Gulia, Seema, et al.
Publicado: (2016)

Reply to Kratz et al.
por: Frebourg, Thierry, et al.
Publicado: (2020)

Reply to Reimann et al.
por: Clarke, Loren E., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_cbomcn8s832gdrmttl4cs8fujv